Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

NCT02989064

Conditions
Bladder Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Completed

A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma

NCT05419388

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Coffs Harbour Health Campus Coffs Harbour, New South Wales, Australia
  • Melanoma Institute Australia North Sydney, New South Wales, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • One Clinical Research Nedlands, Western Australia, Australia
View all 22 locations
View Trial Details
Completed

Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

NCT01983748

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations
  • Dept. of Dermatology, University Hospital Erlangen, Bavaria, Germany
  • University Hospital Department of Ophtalmology Erlangen, Bavaria, Germany
  • University Hospital Department of Ophtalmology Würzburg, Bavaria, Germany
  • Städtisches Klinikum Dessau, Germany
View Trial Details
Completed

IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma

NCT04109456

Conditions
Melanoma, Metastatic Melanoma, Neoplasms, +10 more
Locations
  • Sylvester Comprehensive Cancer Center. Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
View Trial Details

Related conditions